$2.53 -0.05 (%) Sunesis Pharmaceuticals Inc - NASDAQ

Dec. 19, 2014 | 04:00 PM

Partner Headlines

  1. Sunesis Announces Presentation Of Positive Updated Results From Ongoing MD Anderson-Sponsored Trial Of Vosaroxin In AML And High-Risk MDS at ASH Annual Meeting

    Benzinga | Dec. 8, 2014 | 13:32PM EST
  2. Morning Market Losers

    Benzinga | Dec. 8, 2014 | 09:53AM EST
  3. UPDATE: Sunesis Reports Schedule C Had Most Favorably Safety/Efficacy Balance

    Benzinga | Nov. 24, 2014 | 07:24AM EST
  4. Sunesis Announces Publication Of Vosaroxin Phase 1b/2 AML Trial Results In Haematologica

    Benzinga | Nov. 19, 2014 | 07:01AM EST
  5. Sunesis Pharmaceuticals Announces Late-Breaking Presentation Of Phase 3 VALOR Trial At ASH Annual Meeting

    Benzinga | Nov. 17, 2014 | 09:06AM EST
  6. Earnings Scheduled For November 10, 2014

    Benzinga | Nov. 10, 2014 | 05:36AM EST
  7. Sunesis Pharmaceuticals, Inc.'s Flop: More Drugs Out There, Says Roth

    Benzinga | Oct. 7, 2014 | 16:19PM EST
  8. U.S. Stocks Turn Red; CareFusion Shares Surge On Announcement Of Acquisition By Becton, Dickinson

    Benzinga | Oct. 6, 2014 | 14:00PM EST
  9. Markets Open Higher; Hewlett-Packard Plans To Split Into Two Companies

    Benzinga | Oct. 6, 2014 | 10:58AM EST
  10. Stocks Hitting 52-Week Lows

    Benzinga | Oct. 6, 2014 | 10:20AM EST
  11. Benzinga's Top #PreMarket Losers

    Benzinga | Oct. 6, 2014 | 08:08AM EST
  12. Morning Market Losers

    Benzinga | Aug. 29, 2014 | 09:52AM EST
  13. Benzinga's Top Downgrades

    Benzinga | Aug. 29, 2014 | 09:15AM EST
  14. Wedbush Downgrades Sunesis Pharmaceuticals To Neutral, Shares Drop

    Benzinga | Aug. 29, 2014 | 08:31AM EST
  15. UBS Says Sunesis Leukemia Pivotal Trial Success 'Likely'

    Benzinga | Aug. 27, 2014 | 16:05PM EST
  16. Sunesis Pharmaceuticals Announces European Medicines Agency Acceptance of Pediatric Investigation Plan for Qinprezo For AML

    Benzinga | Jul. 9, 2014 | 07:04AM EST
  17. Events Scheduled for Week of Jun. 16th to Jun. 20th

    Benzinga | Jun. 17, 2014 | 10:48AM EST
  18. Sunesis Announces Data of Ongoing Vosaroxin Study at ASCO

    Benzinga | Apr. 22, 2014 | 07:09AM EST
  19. Mid-Morning Market Update: Markets Drop; Family Dollar Plans To Close 370 Stores

    Benzinga | Apr. 10, 2014 | 10:27AM EST
  20. Sunesis Pharmaceuticals Announces Global Licenses for Two Kinase Inhibitor Programs

    Benzinga | Jan. 9, 2014 | 07:06AM EST
  21. Sunesis Pharmaceuticals Announces Investigator-Sponsored Phase I/II Trial Evaluating Vosaroxin in Myelodysplastic Syndrome

    Benzinga | Oct. 28, 2013 | 07:07AM EST
  22. Sunesis Pharmaceuticals Announces Closing of $40 Million in Previously Announced Royalty and Debt Financings

    Benzinga | Sep. 20, 2012 | 01:04AM EST
  23. Stocks Hitting 52-Week Highs

    Benzinga | Sep. 11, 2012 | 04:03AM EST
  24. Morning Market Movers

    Benzinga | Sep. 11, 2012 | 03:48AM EST
  25. From Earlier: Sunesis Pharmaceuticals to Implement One-Time Sample Size Increase to Phase 3 VALOR Trial in AML

    Benzinga | Sep. 11, 2012 | 02:21AM EST
  26. Cantor Fitzgerald Reiterates Buy Rating, $6 PT for Sunesis Pharmaceuticals

    Benzinga | Jun. 15, 2012 | 04:42AM EST
  27. Benzinga's Microcap Movers for Monday March 5, 2012

    Benzinga | Mar. 5, 2012 | 15:18PM EST
Trading Center